Figure 1.
CD36 and CD27 on HIV-1 virions in blood plasma of infected individuals. (a) Gating strategy: threshold trigger setting on fluorescence height of MNP label Zenon Alexa 647. (b) Single gate defined by fluorescence height and fluorescence width, which excludes aggregates12. (c) Flow virometry of 2G12/PG9-captured HIV-1. Populations of CD27+ and CD36+ virions are presented. (d,e) CD27+ and CD36+ on HIV-1 virions captured with 2G12/PG9-MNPs (white asterisks). CD27 (red arrows) (d) and CD36 (green arrows) (e) are revealed by 6-nm colloidal gold particles. (f) Fractions of CD36+ and CD27+ among 2G12/PG9-captured virions as evaluated with flow virometry. Presented are means ± s.e.m. (n = 3). (g) HIV-1 RNA in fractions of virions captured with 2G12/PG9-MNPs, anti-CD36-MNPs, and anti-CD27-MNPs among total blood plasma virions. Presented are means ± s.e.m. (n = 3).